Pendicard Trio 4/1.25/5 Tablet 10

Pendicard Trio Tablet interacts with the following medicines:

• Antihypertensive agents: These medicines, like losartan or metoprolol, may interact with Pendicard Trio Tablet increasing the risk of lower-than-normal blood pressure levels.
• NSAIDs: Medicines such as ibuprofen and naproxen can reduce the blood pressure-lowering effects of this tablet.
• Antimanic agents: Medicines like lithium when taken with this medication can lead to high lithium levels, causing toxicity.
• Cardiac glycoside: Digoxin when used with this tablet, could heighten digoxin levels in your blood and increase the risk of side effects.
• Potassium supplements or potassium-sparing diuretics: If taken together with this tablet, they might lead to increased potassium levels in your blood.

Pendicard Trio Tablet has interactions with certain foods:

• High-potassium foods: Consuming potassium-rich food like bananas and spinach along with this medicine might increase the risk of high potassium levels in your blood.

Pendicard Trio Tablet interacts with the following diseases:

• Diabetes: Due to its effect on insulin and glucose metabolism, diabetic patients should closely monitor their blood sugar levels when taking this medication.
• Gout: This medicine might increase uric acid levels in the body leading to gout attacks.
• Heart disease: With its impact on heart rate and blood pressure, it is crucial for patients with heart problems to use this medication under a doctor's supervision

The daily dose of Pendicard Trio Tablet should be taken as instructed by your doctor. Your dosage may vary based on several factors, including the severity of the condition and response to treatment.

If you take more than the prescribed dosage of Pendicard Trio Tablet, it may lead to symptoms like dizziness or fatigue. If these symptoms persist, consult your doctor.

If you miss a dose of Pendicard Trio Tablet, take it as soon as possible. If it is nearly time for the next dose, skip the missed one and continue your schedule.